IL6 and acute respiratory distress syndrome: Additionally, SCO was found to inhibit TLR4-mediated NF-κB signaling pathway and the expression of TLR4, TNF-α, IL-6 and IL-1β in LPS-stimulated alveolar macrophages, underscoring its efficacy in alleviating LPS-induced ALI (19).